| 1 | 5TW3 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-7-fluoronaphthalene-2-carbonitrile |
7N1 |
 |
0.93 |
SHOW |
| 2 | 6DTW |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-6-fluoroindolizine-2-carbonitrile |
H9Y |
 |
0.87 |
SHOW |
| 3 | 1S1V |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL |
TNK |
 |
0.83 |
SHOW |
| 4 | 6X4B |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-5-fluoro-8-methylnaphthalene-2-carbonitrile |
UMY |
 |
0.82 |
SHOW |
| 5 | 4KV8 |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
11-ethyl-5-methyl-8-[2-(1-oxidanylquinolin-4-yl)oxyethyl]dipyrido[3,2-[1,4]diazepin-6-one |
1WT |
 |
0.82 |
SHOW |
| 6 | 6X4C |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]-4-fluorophenoxy}-5,8-dimethylnaphthalene-2-carbonitrile |
UNS |
 |
0.8 |
SHOW |
| 7 | 6X4A |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-chloro-7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-8-methyl-2-naphthonitrile |
7AY |
 |
0.78 |
SHOW |
| 8 | 6X4D |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
5-(cyclopropylmethyl)-7-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-8-methylnaphthalene-2-carbonitrile |
UO4 |
 |
0.76 |
SHOW |
| 9 | 6X4E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
 |
0.76 |
SHOW |
| 10 | 6X47 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
 |
0.75 |
SHOW |
| 11 | 6X4F |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
methyl (6-cyano-3-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}-4-methylnaphthalen-1-yl)acetate |
UMV |
|
0.74 |
SHOW |
| 12 | 6UL5 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenoxy}thieno[3,2-d]pyrimidin-2-yl)amino]-2-fluorobenzonitrile |
QAG |
 |
0.71 |
SHOW |
| 13 | 1IKX |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE |
PNU |
 |
0.71 |
SHOW |
| 14 | 6X49 |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
7-(2-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy)phenoxy)-2-naphthonitrile |
7AX |
|
0.68 |
SHOW |
| 15 | 1S6Q |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE |
TPB |
 |
0.68 |
SHOW |
| 16 | 1S9E |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 group M subtype B |
P03366 (POL_HV1B1) |
4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE |
ADB |
 |
0.65 |
SHOW |
| 17 | 3MEG |
Reverse transcriptase | Human immunodeficiency virus type 1 group M subtype B |
P04585 (POL_HV1H2) |
4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile |
T27 |
 |
0.65 |
SHOW |
| 18 | 6NW4 |
Indole-3-glycerol phosphate synthase | Saccharolobus solfataricus |
Q06121 (TRPC_SACS2) |
6-NITROBENZOTRIAZOLE |
6NT |
 |
0.46 |
SHOW |
| 19 | 6ETE |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
[2-(1-methyl-1,2,3,4-tetrazol-4-ium-5-yl)ethanoylamino]azanium |
BWK |
 |
0.45 |
SHOW |
| 20 | 2YK1 |
Fab fragment heavy chain | Homo sapiens |
- |
(S)-3-(1-METHYLPYRROLIDIN-2-YL)PYRIDINE |
NCT |
 |
0.44 |
SHOW |
| 21 | 4KYS |
Thiamine pyridinylase I | Clostridium botulinum A str. ATCC 19397 |
- |
3-(4-AMINO-2-METHYL-PYRIMIDIN-5-YLMETHYL)-5-(2-HYDROXY-ETHYL)-4-METHYL-THIAZOL-3-IUM |
VIB |
 |
0.43 |
SHOW |
| 22 | 4X3S |
Chromobox protein homolog 7 | Mus musculus |
Q8VDS3 (CBX7_MOUSE) |
N-TRIMETHYLLYSINE |
M3L |
 |
0.42 |
SHOW |
| 23 | 5PMO |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
 |
0.41 |
SHOW |
| 24 | 5PMP |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 25 | 5PLX |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 26 | 5PMS |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 27 | 2RI7 |
Nucleosome-remodeling factor subunit BPTF | Homo sapiens |
Q12830 (BPTF_HUMAN) |
N-DIMETHYL-LYSINE |
MLY |
 |
0.41 |
SHOW |
| 28 | 5PMX |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 29 | 5PME |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 30 | 5PMW |
Lysine-specific demethylase 4D | Homo sapiens |
Q6B0I6 (KDM4D_HUMAN) |
N-OXALYLGLYCINE |
OGA |
|
0.41 |
SHOW |
| 31 | 3GV6 |
Chromobox protein homolog 6 | Homo sapiens |
O95503 (CBX6_HUMAN) |
N-TRIMETHYLLYSINE |
M3L |
|
0.41 |
SHOW |
| 32 | 3HX8 |
Mlr2180 protein | Mesorhizobium japonicum |
Q98IZ3 (Q98IZ3_RHILO) |
IMIDAZOLE |
IMD |
 |
0.41 |
SHOW |